A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4,200+ peer-reviewed publications and 180+ international guidelines recommendations. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.
We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH.
As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.
Medical Device, Medical and pharmaceutical research, Research and testing, IT, Internet, R&D, Medical technology research and development, Medical and Diagnostic Laboratories, Health Care and Social Assistance
HQ Location
6 rue Ferrus
Paris, Île-de-France 75014, FR
Keywords
Diagnostic non-invasif en hépatologiePionnier en Elastographie quantitativeEvaluation de la fibrose hépatique et de la cirrhosehepatic fibrosisbiological markersmarker analysisclinical markers